Your account is not claimed yet. You can sign up with ORCID to claim your account.

Filomena Fortinguerra

Years Active: 2019-2023
Publications (10 Years): 5

Italian Medicines Agency

Istituto Di Ricerche Farmacologiche Mario Negri (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Italian Medicines Agency Oct 2o 2017

Italy

PhD

Education History

Istituto Di Ricerche Farmacologiche Mario Negri

Italy

PHD :: Mother & Child Health

Publications

Alessandro Perrella, Filomena Fortinguerra, Andrea Pierantozzi, Nicolina Capoluongo, Novella Carannante, Andrea Lo Vecchio, Francesca Futura Bernardi, Francesco Trotta, Agnese Cangini
Hospital Antibiotic Use during COVID-19 Pandemic in Italy. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Alessandro Perrella, Filomena Fortinguerra, Andrea Pierantozzi, Nicolina Capoluongo, Novella Carannante, Andrea Lo Vecchio, Francesca Futura Bernardi, Francesco Trotta, Agnese Cangini
Hospital Antibiotic Use during COVID-19 Pandemic in Italy. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Filomena Fortinguerra, Valeria Belleudi, Francesca Romana Poggi, Serena Perna, Renata Bortolus, Serena Donati, Paola D'Aloja, Roberto Da Cas, Antonio Clavenna, Anna Locatelli, Antonio Addis, Marina Davoli, Francesco Trotta, null null
Monitoring medicine prescriptions before, during and after pregnancy in Italy. PloS one 18 (6) (2023)
Agnese Cangini, Filomena Fortinguerra, Aurora Di Filippo, Andrea Pierantozzi, Roberto Da Cas, Federico Villa, Francesco Trotta, Maria Luisa Moro, Carlo Gagliotti
Monitoring the community use of antibiotics in Italy within the National Action Plan on antimicrobial resistance. British journal of clinical pharmacology 87 (3) (2020)
Filomena Fortinguerra, Giovanni Tafuri, Francesco Trotta, Antonio Addis
Using GRADE methodology to assess innovation of new medicinal products in Italy. British journal of clinical pharmacology 86 (1) (2019)

Filomena Fortinguerra.css-eqlu8i{font-size:small;padding-left:4px;}